Papers authored by Saadane N

Collect these papers and discover other ones on Labmeeting. Learn more.
Diminished molecular response to doxorubicin and loss of cardioprotective effect of dexrazoxane in Egr-1 deficient female mice.
+ cite this
+ View Abstract
Saadane N, Yue P, Alpert L, Mitmaker B, Kirby GM, and Chalifour LE
Canadian journal of physiology and pharmacology 79(6):533-44, 2001 Jun - Who cited this? | PubMed ID: 11430591 | Fulltext
Recommend
Altered molecular response to adrenoreceptor-induced cardiac hypertrophy in Egr-1-deficient mice.
+ cite this
+ View Abstract
Saadane N, Alpert L, and Chalifour LE
American journal of physiology. Heart and circulatory physiology 278(3):H796-805, 2000 Mar - Who cited this? | PubMed ID: 10710348 | Fulltext
Recommend
Expression of immediate early genes, GATA-4, and Nkx-2.5 in adrenergic-induced cardiac hypertrophy and during regression in adult mice.
+ cite this
+ View Abstract
Saadane N, Alpert L, and Chalifour LE
British journal of pharmacology 127(5):1165-76, 1999 Jul - Who cited this? | PubMed ID: 10455263 | Fulltext
Recommend
TAFII250, Egr-1, and D-type cyclin expression in mice and neonatal rat cardiomyocytes treated with doxorubicin.
+ cite this
+ View Abstract
Saadane N, Alpert L, and Chalifour LE
The American journal of physiology 276(3 Pt 2):H803-14, 1999 Mar - Who cited this? | PubMed ID: 10070062 | Fulltext
Recommend
A new therapeutic approach for sickle cell disease. Blockade of the red cell Ca(2+)-activated K+ channel by clotrimazole.
+ cite this
Brugnara C, De Franceschi L, Armsby CC, Saadane N, Trudel M, Beuzard Y, Rittenhouse A, Rifai N, Platt O, and Alper SL
Annals of the New York Academy of Sciences 763:262-71, 1995 Jul 12 - Who cited this? | PubMed ID: 7677336 | Fulltext
Recommend
Sickle cell disease of transgenic SAD mice.
+ cite this
+ View Abstract
Trudel M, De Paepe ME, Chrétien N, Saadane N, Jacmain J, Sorette M, Hoang T, and Beuzard Y
Blood 84(9):3189-97, 1994 Nov 1 - Who cited this? | PubMed ID: 7949191 | Fulltext
Recommend
Treatment with oral clotrimazole blocks Ca(2+)-activated K+ transport and reverses erythrocyte dehydration in transgenic SAD mice. A model for therapy of sickle cell disease.
+ cite this
+ View Abstract
De Franceschi L, Saadane N, Trudel M, Alper SL, Brugnara C, and Beuzard Y
The Journal of clinical investigation 93(4):1670-6, 1994 Apr - Who cited this? | PubMed ID: 7512989 | Fulltext
Recommend
[Physiopathologic and therapeutic importance of animal models of hemoglobinopathies].
+ cite this
Saadane N, Rouyer-Fessard P, Villeval JL, Blumenfeld-Charbit N, Henri A, Leroy-Viard K, Sauvage C, Vicaut E, Maurel A, and Vainchenker W
Nouvelle revue francaise d'hematologie 35(3):301-2, 1993 Jun - Who cited this? | PubMed ID: 8337148 | Fulltext
Recommend
Towards a transgenic mouse model of sickle cell disease: hemoglobin SAD.
+ cite this
+ View Abstract
Trudel M, Saadane N, Garel MC, Bardakdjian-Michau J, Blouquit Y, Guerquin-Kern JL, Rouyer-Fessard P, Vidaud D, Pachnis A, and Roméo PH
The EMBO journal 10(11):3157-65, 1991 Nov - Who cited this? | PubMed ID: 1915288 | Fulltext
Recommend
Towards a mouse model for sickle cell disease: HB SAD.
+ cite this
+ View Abstract
Trudel M, Garel MC, Saadane N, Rouyer-Fessard P, Vidaud D, Costantini F, and Beuzard Y
Nouvelle revue francaise d'hematologie 32(6):407-8, 1990 - Who cited this? | PubMed ID: 2101873 | Fulltext
Recommend



Search Google Scholar for Saadane N

Join Labmeeting

  • Organize and search your PDF collection
  • Collect papers
  • Search millions of papers
  • Keep up to date with paper alerts
  • Read your papers from anywhere
  • Recommend papers to colleagues
  • Manage your lab
Sign Up

Join Labmeeting

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.


Got a question?
The Labmeeting Network
has the answer.
Ask scientists at top universities like Harvard, Stanford, and MIT for their expert opinion!